These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 31206540)

  • 1. "I take my pills every day, but then it goes up, goes down. I don't know what's going on": Perceptions of HIV virological failure in a rural context in Mozambique. A qualitative research study.
    Pulido Tarquino IA; Venables E; de Amaral Fidelis JM; Giuliani R; Decroo T
    PLoS One; 2019; 14(6):e0218364. PubMed ID: 31206540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "I don't know when he will be back": life-changing events challenge the community ART Group model- a qualitative research study, Tete, Mozambique.
    Tarquino IAP; Venables E; Simone RR; de Amaral Fidelis JM; Decroo T
    BMC Public Health; 2021 Nov; 21(1):2004. PubMed ID: 34736432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient experiences of ART adherence clubs in Khayelitsha and Gugulethu, Cape Town, South Africa: A qualitative study.
    Venables E; Towriss C; Rini Z; Nxiba X; Cassidy T; Tutu S; Grimsrud A; Myer L; Wilkinson L
    PLoS One; 2019; 14(6):e0218340. PubMed ID: 31220116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient and health-care worker experiences of an HIV viral load intervention using SMS: A qualitative study.
    Venables E; Ndlovu Z; Munyaradzi D; Martínez-Pérez G; Mbofana E; Nyika P; Chidawanyika H; Garone DB; Bygrave H
    PLoS One; 2019; 14(4):e0215236. PubMed ID: 30973925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of virological failure and antiretroviral drug resistance in Mozambique.
    Rupérez M; Pou C; Maculuve S; Cedeño S; Luis L; Rodríguez J; Letang E; Moltó J; Macete E; Clotet B; Alonso P; Menéndez C; Naniche D; Paredes R
    J Antimicrob Chemother; 2015 Sep; 70(9):2639-47. PubMed ID: 26084302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the front line of HIV virological monitoring: barriers and facilitators from a provider perspective in resource-limited settings.
    Rutstein SE; Golin CE; Wheeler SB; Kamwendo D; Hosseinipour MC; Weinberger M; Miller WC; Biddle AK; Soko A; Mkandawire M; Mwenda R; Sarr A; Gupta S; Mataya R
    AIDS Care; 2016; 28(1):1-10. PubMed ID: 26278724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perspectives on the utility and interest in a point-of-care urine tenofovir test for adherence to HIV pre-exposure prophylaxis and antiretroviral therapy: an exploratory qualitative assessment among U.S. clients and providers.
    Bardon AR; Simoni JM; Layman LM; Stekler JD; Drain PK
    AIDS Res Ther; 2020 Aug; 17(1):50. PubMed ID: 32762713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline HIV-1 resistance, virological outcomes, and emergent resistance in the SECOND-LINE trial: an exploratory analysis.
    Boyd MA; Moore CL; Molina JM; Wood R; Madero JS; Wolff M; Ruxrungtham K; Losso M; Renjifo B; Teppler H; Kelleher AD; Amin J; Emery S; Cooper DA;
    Lancet HIV; 2015 Feb; 2(2):e42-51. PubMed ID: 26424460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A qualitative assessment of a community antiretroviral therapy group model in Tete, Mozambique.
    Rasschaert F; Telfer B; Lessitala F; Decroo T; Remartinez D; Biot M; Candrinho B; Mbofana F; Van Damme W
    PLoS One; 2014; 9(3):e91544. PubMed ID: 24651523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High turnaround times and low viral resuppression rates after reinforced adherence counselling following a confirmed virological failure diagnostic algorithm in HIV-infected patients on first-line antiretroviral therapy from Tanzania.
    Kroidl A; Burger T; Urio A; Mugeniwalwo R; Mgaya J; Mlagalila F; Hoelscher M; Däumer M; Salehe O; Sangare A; Lennemann T; Maganga L
    Trop Med Int Health; 2020 May; 25(5):579-589. PubMed ID: 31984634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV viral suppression in TREAT Asia HIV Observational Database enrolled adults on antiretroviral therapy at the Social Health Clinic, the National Center for HIV/AIDS, Dermatology & STDs, Phnom Penh, Cambodia.
    Boettiger DC; Khol V; Durier N; Law M; Sun LP
    Antivir Ther; 2016; 21(8):725-730. PubMed ID: 27124891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virological failure after 1 year of first-line ART is not associated with HIV minority drug resistance in rural Cameroon .
    Zoufaly A; Jochum J; Hammerl R; Nassimi N; Raymond Y; Burchard GD; Schmiedel S; Drexler JF; Campbell NK; Taka N; Awasom C; Metzner KJ; van Lunzen J; Feldt T
    J Antimicrob Chemother; 2015 Mar; 70(3):922-5. PubMed ID: 25428920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The viral load monitoring cascade in a resource-limited setting: A prospective multicentre cohort study after introduction of routine viral load monitoring in rural Lesotho.
    Glass TR; Motaboli L; Nsakala B; Lerotholi M; Vanobberghen F; Amstutz A; Lejone TI; Muhairwe J; Klimkait T; Labhardt ND
    PLoS One; 2019; 14(8):e0220337. PubMed ID: 31461455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acceptability of lifelong treatment among HIV-positive pregnant and breastfeeding women (Option B+) in selected health facilities in Zimbabwe: a qualitative study.
    Chadambuka A; Katirayi L; Muchedzi A; Tumbare E; Musarandega R; Mahomva AI; Woelk G
    BMC Public Health; 2017 Jul; 18(1):57. PubMed ID: 28743251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High rate of virological failure and low rate of switching to second-line treatment among adolescents and adults living with HIV on first-line ART in Myanmar, 2005-2015.
    Kyaw NT; Harries AD; Kumar AM; Oo MM; Kyaw KW; Win T; Aung TK; Min AC; Oo HN
    PLoS One; 2017; 12(2):e0171780. PubMed ID: 28182786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiretroviral therapy initiation and adherence in rural South Africa: community health workers' perspectives on barriers and facilitators.
    Loeliger KB; Niccolai LM; Mtungwa LN; Moll A; Shenoi SV
    AIDS Care; 2016 Aug; 28(8):982-93. PubMed ID: 27043077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virological outcomes of antiretroviral therapy in Zomba central prison, Malawi; a cross-sectional study.
    Mpawa H; Kwekwesa A; Amberbir A; Garone D; Divala OH; Kawalazira G; van Schoor V; Ndindi H; van Oosterhout JJ
    J Int AIDS Soc; 2017 Aug; 20(1):21623. PubMed ID: 28782332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral load detection and management on first line ART in rural Rwanda.
    Ndagijimana Ntwali JD; Decroo T; Ribakare M; Kiromera A; Mugwaneza P; Nsanzimana S; Lynen L
    BMC Infect Dis; 2019 Jan; 19(1):8. PubMed ID: 30606128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of HIV-1 low-level viraemia during antiretroviral therapy on treatment outcomes in WHO-guided South African treatment programmes: a multicentre cohort study.
    Hermans LE; Moorhouse M; Carmona S; Grobbee DE; Hofstra LM; Richman DD; Tempelman HA; Venter WDF; Wensing AMJ
    Lancet Infect Dis; 2018 Feb; 18(2):188-197. PubMed ID: 29158101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individual factors associated with time to non-adherence to ART pick-up within HIV care and treatment services in three health facilities of Zambézia Province, Mozambique.
    Filimão DBC; Moon TD; Senise JF; Diaz RS; Sidat M; Castelo A
    PLoS One; 2019; 14(3):e0213804. PubMed ID: 30908522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.